Emerald Acquisition’s BioSpecifics Technologies BSTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTC
ECP
Emerald Acquisition's BSTC Position: Q3 2016 in Review
Emerald Acquisition reduced its BioSpecifics Technologies (BSTC) stake by 22% in Q3 2016, selling an estimated $652K and leaving 56,500 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #1608.
Emerald Acquisition first reported a position in BSTC in Q2 2016 and has held it in 2 quarters since. The position peaked at $2.9M in Q2 2016. 90 funds tracked by Wall St. Rank hold BSTC as of Q3 2016.
- Emerald Acquisition held 56,500 shares of BioSpecifics Technologies worth $2.58M as of Q3 2016.
- Emerald Acquisition sold 16,224 BioSpecifics Technologies shares in Q3 2016, an estimated $652K.
- BioSpecifics Technologies made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1608 holding.
- Emerald Acquisition first reported a position in BioSpecifics Technologies in Q2 2016 and has held it in 2 quarters since.
- Emerald Acquisition's BioSpecifics Technologies position peaked at $2.9M in Q2 2016.
- 90 funds tracked by Wall St. Rank held BioSpecifics Technologies as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.